{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1347","meta":{"versionId":"5","lastUpdated":"2021-02-02T15:29:33.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1347","version":"20170504","name":"Naloxone / Pentazocine","status":"active","date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"312289","display":"Naloxone 0.5 MG / Pentazocine 50 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:51d6b28b-23f8-4389-9b54-22835d7899cf","timestamp":"2022-06-10T09:58:53-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"312289","display":"naloxone 0.5 MG / pentazocine 50 MG Oral Tablet"}]}}